We are live on ! Find out more
SNTI icon

Senti Biosciences Holdings
SNTI

44 hedge funds and large institutions have $202M invested in Senti Biosciences Holdings in 2021 Q2 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

8.8% more ownership

Funds ownership: 0% → 8.8% (+8.8%)

Holders
44
Holders Change
+44
Holders Change %
–
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$29.9M
2
Morgan Stanley
Morgan Stanley
New York
+$28.9M
3
AIM
ARK Investment Management
Florida
+$20.8M
4
RG
Redmile Group
California
+$20.1M
5
WP
Woodline Partners
California
+$20M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$29.8M +$29.9M +300,000 New
Morgan Stanley
2
Morgan Stanley
New York
$28.8M +$28.9M +289,423 New
AIM
3
ARK Investment Management
Florida
$20.7M +$20.8M +208,651 New
RG
4
Redmile Group
California
$20M +$20.1M +201,290 New
WP
5
Woodline Partners
California
$19.9M +$20M +200,000 New
DCP
6
D1 Capital Partners
New York
$19.4M +$19.5M +195,000 New
AG
7
Artal Group
Luxembourg
$4.97M +$4.99M +50,000 New
APM
8
Avidity Partners Management
Texas
$4.97M +$4.99M +50,000 New
Millennium Management
9
Millennium Management
New York
$4.33M +$4.35M +43,590 New
SRF
10
Silver Rock Financial
California
$4.16M +$4.17M +41,798 New
Marshall Wace
11
Marshall Wace
United Kingdom
$3.98M +$3.99M +40,000 New
GL
12
Governors Lane
New York
$3.48M +$3.49M +35,000 New
Blackstone Inc
13
Blackstone Inc
New York
$2.98M +$2.99M +30,000 New
CCM
14
Cinctive Capital Management
New York
$2.98M +$2.99M +30,000 New
Jane Street
15
Jane Street
New York
$2.98M +$2.99M +30,003 New
PVI
16
Pura Vida Investments
New York
$2.48M +$2.49M +25,000 New
AA
17
AQR Arbitrage
Connecticut
$2.16M +$2.17M +21,751 New
AIMCA
18
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$1.99M +$2M +20,000 New
SSA
19
Schonfeld Strategic Advisors
New York
$1.99M +$1.99M +19,994 New
CH
20
CVI Holdings
Delaware
$1.89M +$1.9M +19,020 New
SC
21
Sculptor Capital
New York
$1.88M +$1.88M +18,880 New
Citadel Advisors
22
Citadel Advisors
Florida
$1.79M +$1.8M +18,040 New
NIP
23
Nicholas Investment Partners
California
$1.74M +$1.75M +17,500 New
MS
24
Maven Securities
Jersey
$1.15M +$1.15M +11,532 New
HighTower Advisors
25
HighTower Advisors
Illinois
$1.09M +$1.09M +10,900 New
1
2

SNTI Hedge Fund Activity: Q2 2021 in Review

44 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q2 2021, worth a combined $202M.

Buyers outnumbered sellers: 44 funds opened new SNTI positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $29.9M.

  • 44 institutional investors held Senti Biosciences Holdings (SNTI) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $202M of Senti Biosciences Holdings stock for Q2 2021.
  • 44 funds opened new Senti Biosciences Holdings positions in Q2 2021 and 0 closed out, a net change of +44 holders.
  • The largest Senti Biosciences Holdings buyer in Q2 2021 was T. Rowe Price Associates, an estimated $29.9M added.

Based on aggregated 13F filings for Q2 2021.